Medical castration with LHRH agonists is a significant trend in the treatment of locally advanced and metastatic prostate cancer (PC). The article is devoted to the effectiveness of synthetic LHRH agonist buserelin (Buserelin-depo) in the treatment of patients with hormone dependent PC. Administration of Buserelin-depot results in a decrease of the prostate-specific antigen levels. st... https://www.ealisboa.com/mega-pick-2002-2003-LEXUS-ES300-Sedan-3-0L-Coolant-Recovery-Reservoir-Bottle-Overflow-Tank-hot-grab/